Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloroform SCHEMBL2007196 | 0.97 | CYP1A2 (0.31) | CYP2C9HPGDMAPK1HSD17B10CYP1A2 | |
| Chloroform SCHEMBL378302 | 0.93 | LMNA (0.33) | — | |
| Cyclohexane SCHEMBL11847430 | 0.91 | — | — | |
| Chloroform SCHEMBL537028 | 0.90 | ALDH1A1 (0.40) | CYP2C9HPGDMAPK1HSD17B10CYP1A2 | |
| Chloroform SCHEMBL7930106 | 0.89 | LMNA (0.31) | — | |
| Isopropyl Alcohol SCHEMBL6666765 | 0.88 | ALDH1A1 (0.33) | ALDH1A1 | |
| Hexane SCHEMBL27647104 | 0.88 | PLA2G1B (0.41) | HSD17B10ALDH1A1MEN1THRBKMT2A | |
| Chloroform SCHEMBL8348906 | 0.87 | ALDH1A1 (0.38) | CYP2C9HPGDMAPK1HSD17B10CYP1A2 | |
| Chloromethane SCHEMBL375766 | 0.85 | CYP2C9 (0.35) | CYP2C9HPGDMAPK1HSD17B10CYP1A2 | |
| Methyl Alcohol SCHEMBL341831 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 380 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101554417-B | Quality control method of antitumor Chinese medicine composition | NANJING ZHONGKE GROUP CO LTD | 2011-09-21 | — | — | CN | claimed |
| CN-101554417-A | Quality control method of antitumor Chinese medicine composition | NANJING ZHONGKE GROUP CO LTD (CN) | 2009-10-14 | — | — | CN | claimed |
| EP-4349846-A1 | CHIMERIC NUCLEIC ACID OLIGOMER INCLUDING PHOSPHOROTHIOATE AND BORANOPHOSPHATE, AND METHOD FOR PRODUCING SAME | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2024-04-10 | — | — | EP | disclosed |
| CN-117412983-A | Chimeric nucleic acid oligomer comprising phosphorothioate and borazine phosphate, and method for producing same | 学校法人东京理科大学 | 2024-01-16 | — | — | CN | disclosed |
| US-11845724-B2 | USP30 inhibitors and uses thereof | VINCERE BIOSCIENCES, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| WO-2023191088-A1 | PLANT-DERIVED ORGANOCATALYST | 協和ファーマケミカル株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023105494-A1 | CATIONIC STEROID COMPOUNDS, METHOD OF OBTAINING THEREOF, FORMULATIONS COMPRISING THEREOF AND THEIR USES | UNIVERSIDADE DO PORTO (PT) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023085392-A1 | ANTI-SARS-COV-2 DRUG | 国立大学法人鹿児島大学 | 2023-05-19 | — | — | WO | disclosed |
| US-11638717-B2 | Complex of nucleic acid medicine and multibranched lipid | SHIONOGI & CO., LTD. (JP) | 2023-05-02 | — | — | US | disclosed |
| WO-2022255469-A1 | CHIMERIC NUCLEIC ACID OLIGOMER INCLUDING PHOSPHOROTHIOATE AND BORANOPHOSPHATE, AND METHOD FOR PRODUCING SAME | 学校法人東京理科大学 | 2022-12-08 | — | — | WO | disclosed |
| US-20220315531-A1 | USP30 INHIBITORS AND USES THEREOF | VINCERE BIOSCIENCES, INC. | 2022-10-06 | — | — | US | disclosed |
| US-4096146-A | ANTIMALARIA, ANTIARRHYTHMIA | HOFFMANN-LA ROCHE INC. (US) | 1978-06-20 | — | — | US | disclosed |
| US-4093610-A | CYCLIC DODECAPEPTIDE, MULTISTAGE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
| US-4091115-A | ANTIDEPRESSANTS | ROUSSEL UCLAF (FR) | 1978-05-23 | — | — | US | disclosed |
| US-4064339-A | Antibiotic aminoglycosides, processes of preparation and pharmaceutical compositions | ROUSSEL UCLAF (FR) | 1977-12-20 | — | — | US | disclosed |
| US-4009273-A | CNS STIMULANTS | ROUSSEL-UCLAF (FR) | 1977-02-22 | — | — | US | disclosed |
| US-3953453-A | ANTIMALARIAL AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1976-04-27 | — | — | US | disclosed |
| US-3931151-A | ANTIDEPRESSANT, NEURO-SEDATIVE | ROUSSEL-UCLAF (FR) | 1976-01-06 | — | — | US | disclosed |
| US-3931193-A | ANTIMALARIA, ANTIARRHYTHMIA INTERMEDIATES | HOFFMANN-LA ROCHE INC. (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931192-A | Process for piperidine intermediates for quinine, quinidine and analogs thereof | HOFFMANN-LA ROCHE INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11638717-B2 | Complex of nucleic acid medicine and multibranched lipid | FABP1, POLRMT, SREBF1 | CYP2C9 4044/4885HPGD 4766/4885MAPK1 4801/4885 |
| US-11845724-B2 | USP30 inhibitors and uses thereof | USP30, USP28, USP1 | CYP2C9 4412/4885HPGD 3509/4885MAPK1 2205/4885 |
| US-20220315531-A1 | USP30 INHIBITORS AND USES THEREOF | USP30, USP28, USP1 | CYP2C9 4412/4885HPGD 3509/4885MAPK1 2205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.